NovMetaPharma is carrying out all stages of new drug development from discovery of the new drug candidates to GMP production, preclinical and clinical trials, new drug approval, and commercialization.
Program Target | Products | IP Strategy | Country |
---|---|---|---|
Core substance-based medication | Substance patent | US (plus PCT international patent applications) | |
Diabetes medication | NovDB2 | Diabetes dosage patent | Korea / USA (plus PCT international patent applications) |
Compound medication patent | Korea / USA / Europe / China / Hong Kong / Japan | ||
NovAQ | Single medication patent | Korea / USA / Europe / China / Japan | |
Compound medication patent 1 | Korea / USA / Europe / China / Hong Kong / Japan | ||
Compound medication patent 2 | Korea (plus PCT international patent applications) | ||
Anti-obesity medication | NovOB | Obesity basic patent | USA / England / Germany |
Obesity dosage patent | Korea (plus PCT international patent applications) | ||
Liver and kidney medication | NovRD | Cell protection patent | Korea / USA / Europe / China / Japan |
Fibrosis medication | NovFS | Fibrosis prevention and improvement patent | Korea (plus PCT international patent applications) |
NovRF | Retroperitoneal fibrosis prevention and treatment patent | Korea (plus PCT international patent applications) | |
Inflammatory bowel disease medication | NovIB | inflammatory bowel disease treatment and prevention patent | USA (plus PCT international patent applications) |
Viral disease medication | Nov19 | Antiviral patent | USA (plusPCT international patent applications) |
Vascular disease medication | NovAS | Arteriosclerosis patent | USA (plus PCT international patent applications) |
NovBP | Blood pressure drop patent | Korea (plus PCT international patent applications) | |
Bone loss disease medication | NovHO | Osteoporosis patent | Korea (plus PCT international patent applications) |
NovOS | Osteoporosis patent | Korea / USA / Europe / China / Japan | |
Osteoporosis compound medication patent | Korea (plus PCT international patent applications) | ||
Antithrombotic and female menopause medication | NovBH | Antithrombotic patent | Korea / USA / Europe / China / Japan |
NovWH | Female menopause patent | Korea | |
Cognitive impairment medication | NovCO | Cognitive impairment prevention and improvement patent | Korea (plus PCT international patent applications) |
Alzheimer’s disease medication | NovAD | AD basic patent | Korea / USA |
Dopamine patent | Korea | ||
Acute pancreatitis medication | NovAP | Acute pancreatitis use patent | USA (plus PCT international patent applications) |
Degenerative brain disease medication | NovGP | Degenerative brain disease patent 1 | Korea (plus PCT international patent applications) |
NovHB | Degenerative brain disease patent 2 | Korea (plus PCT international patent applications) | |
Liver cancer medication | NovLC | Liver cancer use patent | Korea (plus PCT international patent applications) |
Cytokine inhibitor | NovCK | Cytokine inhibition patent | USA (plus PCT international patent applications) |
Exercise performance enhancement | NovGR | Exercise performance enhancement compound medication patent | Korea / USA / China |
NovMR | Exercise performance enhancement patent | USA / Japan |